Cargando…
A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies
Thrombosis has emerged as an important complication of coronavirus disease 2019 (COVID-19), particularly among individuals with severe illness. However, the precise incidence of thrombotic events remains uncertain due to differences in study design, patient populations, outcome ascertainment, event...
Autores principales: | Siegal, Deborah M., Barnes, Geoffrey D., Langlois, Nicole J., Lee, Adrienne, Middeldorp, Saskia, Skeith, Leslie, Wood, William A., Le Gal, Grégoire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756982/ https://www.ncbi.nlm.nih.gov/pubmed/33351119 http://dx.doi.org/10.1182/bloodadvances.2020003269 |
Ejemplares similares
-
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
por: Whitworth, Hilary, et al.
Publicado: (2021) -
Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature
por: Bistervels, Ingrid M., et al.
Publicado: (2021) -
Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
por: Crobach, Monique J. T., et al.
Publicado: (2023) -
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
por: Sarkar, Amrita, et al.
Publicado: (2023) -
COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)